Literature DB >> 18085382

Large cell neuroendocrine carcinoma of the lung with calcification and expression of osteopontin.

Naoto Kuroda1, Nobumasa Hamaguchi, Masahiko Ohara, Takashi Hirouchi, Keiko Mizuno, Gang-Hong Lee.   

Abstract

A large cell neuroendocrine carcinoma (LCNEC) is a rare neoplasm. In this article, we report a case of LCNEC with stromal calcification. A 46-year-old Japanese man was found to have an abnormal shadow in the left upper lobe in a chest X-ray. As the size of the tumor increased during the follow-up, a left upper lobectomy was performed. Histological examination disclosed neuroendocrine morphology consisting of large cells, and subsequent immunohistochemistry confirmed the neuroendocrine differentiation. A diagnosis of LCNEC was established. Additionally, calcification was observed in the stroma within the tumor. Immunohistochemically, parts of neoplastic cells of LCNEC and calcified foci were positive for osteopontin. Finally, we suggest that osteopontin as well as dystrophy within the tumor may be involved in the stromal calcification of LCNEC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18085382     DOI: 10.1007/s00795-007-0348-9

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  7 in total

Review 1.  Osteopontin: a versatile regulator of inflammation and biomineralization.

Authors:  C M Giachelli; S Steitz
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

2.  Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.

Authors:  W D Travis; R I Linnoila; M G Tsokos; C L Hitchcock; G B Cutler; L Nieman; G Chrousos; H Pass; J Doppman
Journal:  Am J Surg Pathol       Date:  1991-06       Impact factor: 6.394

3.  Calcification in large cell neuroendocrine carcinoma of the lung.

Authors:  Kazuya Takamochi; Tomoyuki Yokose; Junji Yoshida; Mitsuyo Nishimura; Hironobu Ohmatsu; Kanji Nagai; Yutaka Nishiwaki; Atsushi Ochiai
Journal:  Jpn J Clin Oncol       Date:  2003-01       Impact factor: 3.019

4.  CT findings of surgically resected large cell neuroendocrine carcinoma of the lung in 38 patients.

Authors:  Yasuji Oshiro; Masahiko Kusumoto; Yoshihiro Matsuno; Hisao Asamura; Ryousuke Tsuchiya; Hiroshi Terasaki; Hidefumi Takei; Arafumi Maeshima; Sadayuki Murayama; Noriyuki Moriyama
Journal:  AJR Am J Roentgenol       Date:  2004-01       Impact factor: 3.959

5.  CT demonstration of calcification in carcinoma of the lung.

Authors:  R G Grewal; J H Austin
Journal:  J Comput Assist Tomogr       Date:  1994 Nov-Dec       Impact factor: 1.826

6.  Osteopontin expression and distribution in human carcinomas.

Authors:  L F Brown; A Papadopoulos-Sergiou; B Berse; E J Manseau; K Tognazzi; C A Perruzzi; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

7.  Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

Authors:  A Bellahcène; V Castronovo
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

  7 in total
  3 in total

1.  Chromophobe renal cell carcinoma: useful diagnostic application of imprint cytology and fluorescence in situ hybridization of chromosomes 10 and 21 in two cases of typical and eosinophilic variants.

Authors:  Naoto Kuroda; Kazunobu Katto; Tadanori Yamaguchi; Takako Kawada; Yoshiaki Imamura; Ondrej Hes; Michal Michal; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2008-12-24       Impact factor: 2.309

Review 2.  Role of the metastasis-promoting protein osteopontin in the tumour microenvironment.

Authors:  Pieter H Anborgh; Jennifer C Mutrie; Alan B Tuck; Ann F Chambers
Journal:  J Cell Mol Med       Date:  2010-07-01       Impact factor: 5.310

Review 3.  Molecular Aspects of Thyroid Calcification.

Authors:  Luciana Bueno Ferreira; Etel Gimba; João Vinagre; Manuel Sobrinho-Simões; Paula Soares
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.